Title: Evaluation of Post-Placental and Intra-Cesarean Insertion of Copper-T 380A as a Method of Contraception

Authors: Renu Jain, Jyoti Bindal

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i6.146

Abstract

Background: Increasing rates of institutional deliveries create opportunities for providing quality postpartum family planning services. PPIUCD appears an ideal method for limiting and spacing births. The objective of present study was to evaluate the acceptance, safety and efficacy of postplacental and intracesarean Cu- T 380 A IUCD insertion as a method of contraception.

Material and Methods: 360 women admitted for delivery in the department of Obstetrics and Gynaecology, Gajra Raja Medical College, Gwalior (M.P.), fulfilling the inclusion criteria were counseled for PPIUCD insertion. Cu T 380 A was inserted within 10 minutes of delivery of placenta in 164 women who had no contraindications for PPIUCD. The women were followed up at 6 weeks and 6 months after delivery. Acceptability and outcome in terms of side effects, removal and expulsion were noted and analyzed.

Result: Out of 360 women who were counseled, 164 (45.55%) women accepted the PPIUCD insertion. 54.26% women had post-placental and 45.73% women had intra-caesarean PPIUCD insertion. Majority of women who accepted insertion were in age group 20-24 years and were primipara. Expulsion rate was 3.95%. Cu-T was removed in 14 women. Missing strings was the most common complication and was the most common reason for removal. There were no cases of uterine perforation and pregnancy.

Conclusion: Post-placental and intra-cesarean insertion of Cu-T 380 A is an effective, safe, long term and convenient method of contraception for limiting and spacing births.

Keywords: PPIUCD (Postpartum intrauterine contraceptive device), acceptance, expulsion.

References

  1. Postpartum IUCD reference manual. Family planning division, Ministry of Health and Family Welfare, Government of India. New Delhi:2010.
  2. Cleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Family planning: the unfinished agenda. Lancet. 2006; 368 (9549): 1810-1827.
  3. World Health Organization: Medical Eligibility Criteria for contraceptive use. 5th Geneva. World Health Organization. 2015
  4. Katheit G, Agarwal J. Evaluation of post-placental intrauterine device (PPIUCD) in terms of awareness, acceptance, and expulsion in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2013 Dec; 2(4): 539-543.
  5. Hooda R, Mann S, Nanda S, Gupta A, More H, et al. Immediate postpartum intrauterine contraceptive device insertions in caesarean and vaginal deliveries: A comparative study of follow up outcomes. International Journal of Reproductive Medicine. 2016;2016, Article ID 7695847: 1-5.                     
  6. Halder A, Sowmya MS, Abhimannyu G, Bhattacharya P, Mukherjee S. A prospective study to evaluate vaginal insertion and intra- Cesarean insertion of post-partum intrauterine contraceptive device. The Journal of Obstetrics and Gynaecology of India. 2016 ( Jan – Feb); 66 (1): 35-41.  
  7. Agarwal N, Gupta M, Agrawal A, Sharma A. Efficacy and safety of post-partum intrauterine contraceptive device (PPIUCD)- A prospective study. Santosh University Journal of Health Sciences. 2017; 3 (1): 20-23.  
  8. Nayak AK, Jain MK. Experience on awareness, acceptability, safety, efficacy complications and expulsion of post-partum intrauterine device insertion. International Journal of Scientific Study. 2017 April. 5 (1): 207- 212. 
  9. Jairaj S, Dayyala S. A cross sectional study on acceptability and safety of IUCD among postpartum mothers at tertiary care hospital, Telangana. Journal of Clinical and Diagnostic Research. 2016 Jan; 10 (1): L001-L004.

Corresponding Author

Dr Renu Jain

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.